(2s,4s)-4-hydroxy-2-(1-methylethyl)-4-[(4r,13s)-18-[methyl(methylsulfonyl)amino]-2,15-dioxo-4-phenyl-11-oxa-3,14-diazatricyclo[14.3.1.1~5,9~]henicosa-1(20),5(21),6,8,16,18-hexaen-13-yl]-n-(2-methylpropyl)butanamide (3OX) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.125
Number of clusters 41
Number of clusters representing 95% 10
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 1.1121
ΔGstrain (kcal/mol) 0.0320
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 1614 0 1.6293
2 1529 0.0320 1.2152
3 1310 0.1235 2.8307
4 1116 0.2184 2.5383
5 1096 0.2292 1.8723
6 1088 0.2335 1.7359
7 977 0.2972 2.6427
8 318 0.9619 1.8942
9 304 0.9886 2.3555
10 292 1.0124 2.4698
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)